{"meshTags":["Antineoplastic Combined Chemotherapy Protocols","Bone Marrow","Carboplatin","Carcinoma, Small Cell","Cyclophosphamide","Dexamethasone","Doxorubicin","Etoposide","Female","Humans","Ifosfamide","Immunologic Factors","Injections, Spinal","Interferon-gamma","Lung Neoplasms","Meningeal Neoplasms","Middle Aged","Morphine","Teniposide","Vincristine"],"meshMinor":["Antineoplastic Combined Chemotherapy Protocols","Bone Marrow","Carboplatin","Carcinoma, Small Cell","Cyclophosphamide","Dexamethasone","Doxorubicin","Etoposide","Female","Humans","Ifosfamide","Immunologic Factors","Injections, Spinal","Interferon-gamma","Lung Neoplasms","Meningeal Neoplasms","Middle Aged","Morphine","Teniposide","Vincristine"],"organisms":["9606"],"publicationTypes":["Case Reports","Journal Article"],"abstract":"A female patient with small cell lung cancer and extensive bone marrow metastases achieved a complete response after combination chemotherapy including etoposide. During maintenance therapy meningeal carcinomatosis was diagnosed. After intravenous administration of teniposide she improved dramatically during 3 months.","title":"Teniposide for meningeal carcinomatosis of small cell lung cancer.","pubmedId":"8075970"}